Reminder – Registration for WADA’s 2022 Annual Symposium and Dedicated Athlete Session

annual symposium

Deadline to register is 27 May

Further to our communication of 30 March 2022, the World Anti-Doping Agency (WADA) encourages stakeholders to register for its 2022 Annual Symposium, which will be held in a hybrid fashion (in-person/virtual) on 11-12 June at the SwissTech Convention Center in Lausanne, Switzerland. A dedicated Athlete Session will be held on 13 June at the same venue.

Under the theme “Raising the Game”, the Annual Symposium will once again gather anti-doping practitioners from International Federations, National and Regional Anti-Doping Organizations and Major Event Organizations, athletes and athlete representatives, Governments, WADA-accredited laboratories and Athlete Passport Management Units, as well as other stakeholders such as service providers, researchers and the media – all that are integral to clean sport.

As outlined within the preliminary program, this year’s edition will, in particular, explore how we can further advance anti-doping together for the benefit of athletes worldwide. This will include a mix of plenary and breakout sessions, as well as discussions on some of the developing innovations in anti-doping.

Dedicated Athlete Session on 13 June

Under the leadership of WADA’s Athlete Committee, a session exclusively for athletes and athlete representatives will take place on 13 June. Anti-Doping Organizations are kindly asked to encourage participation of their athlete representatives -- with one representative per organization being invited to participate free of charge. More information on the program will be provided in the coming days.

Registration for the Symposium and Athlete Session

We invite you to register online for the Symposium and/or the Athlete Session. The Symposium website contains all relevant information regarding the event, including how to register and book your hotel accommodation. The registration deadline is 27 May 2022.

WADA is committed to ensuring the health and safety of its stakeholder community and the Agency’s staff who will attend the Symposium in person. We will therefore continue to monitor the evolution of the pandemic and base our safety protocols on directives from public health authorities related to COVID-19.

We very much look forward to welcoming you to the Symposium after more than three years of absence since the last event due to the pandemic.

Should you have any questions, please contact the secretariat of the Annual Symposium at